TFIIH & Transcription (Keystone)

Transcription factor II human (TFIIH) is an important protein complex with roles in transcription of several protein-coding genes as well as in the nucleotide excision repair pathway. Here is the latest research relating to Dylan J. Taatjes' talk on new model for TFIIH function in transcription.

May 10, 2020
Review
Open Access

CDK7 inhibitors as anticancer drugs

Cancer Metastasis Reviews
Georgina P SavaSimak Ali
December 18, 2019

Approach to Slitlike Ventricles: Parietal-Occipital versus Frontal Burr Catheter Entry Sites

World Neurosurgery
Claudia L CravenAhmed K Toma
January 23, 2020
Review

Drosophila as a Model Organism to Understand the Effects during Development of TFIIH-Related Human Diseases

International Journal of Molecular Sciences
Mario Zurita, Juan Manuel Murillo-Maldonado
July 6, 2019

Gene modification by fast-track recombineering for cellular localization and isolation of components of plant protein complexes

The Plant Journal : for Cell and Molecular Biology
Zhoubo HuCsaba Koncz
May 22, 2020

Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters

Proceedings of the National Academy of Sciences of the United States of America
Dinesh VermaSankar Swaminathan
January 25, 2020
Preprint
Open Access

Transcription factor enrichment analysis (TFEA): Quantifying the activity of hundreds of transcription factors from a single experiment

BioRxiv : the Preprint Server for Biology
Jonathan D RubinRobin D Dowell
May 9, 2019
Open Access

TFIIE orchestrates the recruitment of the TFIIH kinase module at promoter before release during transcription

Nature Communications
Emmanuel CompeJean-Marc Egly
January 16, 2020
Review

The Structures of Eukaryotic Transcription Pre-initiation Complexes and Their Functional Implications

Sub-cellular Biochemistry
Basil J Greber, Eva Nogales
March 27, 2020
Open Access

Global Transcription Profiles of Anaplasma phagocytophilum at Key Stages of Infection in Tick and Human Cell Lines and Granulocytes

Frontiers in Veterinary Science
Curtis M NelsonUlrike G Munderloh
January 8, 2020

BPC transcription factors and a Polycomb Group protein confine the expression of the ovule identity gene SEEDSTICK in Arabidopsis

The Plant Journal : for Cell and Molecular Biology
Rosanna PetrellaVeronica Gregis
March 7, 2020
Open Access

Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled Repair

Cell
Yuka NakazawaTomoo Ogi
May 17, 2020
Review
Open Access

Spironolactone and XPB: An Old Drug with a New Molecular Target

Biomolecules
Ryan D GabbardMichael G Kemp
September 4, 2019
Preprint
Open Access

Suppression of p53 response by targeting p53-Mediator binding with a stapled peptide

BioRxiv : the Preprint Server for Biology
Ben L AllenDylan J Taatjes
April 3, 2020
Review
Open Access

Structure and mechanism of the RNA polymerase II transcription machinery

Genes & Development
Allison C Schier, Dylan J Taatjes
August 9, 2019
Open Access

Pol II phosphorylation regulates a switch between transcriptional and splicing condensates

Nature
Yang Eric GuoRichard A Young
October 11, 2019
Review

High-resolution cryo-EM structures of TFIIH and their functional implications

Current Opinion in Structural Biology
Eva Nogales, Basil J Greber

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Bivalency & Gene Expression (Keystone)

Bivalent chromatin are segments of DNA, bound to histone proteins, that have both repressing and activating epigenetic regulators in the same region. Here is the latest research on bivalent chromatin and gene expression.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

© 2020 Meta ULC. All rights reserved
/feed-previews/tfiih-transcription-keystone/649ab41d-c5ab-48c1-ba14-e6296c00f32c